Jagran Prakashan

Jagran Prakashan reports a **30% year-over-year decline in net profit** for Q2 FY2027, totaling **₹41 crore**. The company’s financial performance reflects a significant downturn compared to the same period last year. No specific reasons for the drop are provided in the brief announcement.

Nov 2026ScanX NewsNews article

Mankind Pharma secures approval from the National Company Law Tribunal (NCLT) Allahabad for relocating its corporate office. The decision follows proceedings held on **7 October 2026**, marking a procedural milestone for the company’s operational restructuring. The move aligns with regulatory updates for registered corporate addresses in India.

Oct 2026Kalkine MediaNews article

Jagran Prakashan Limited declares a special dividend of **₹3 per equity share** for the financial year ended **March 31, 2026**. The dividend was approved at a board meeting on **May 28, 2026**, with the same date set as the record date for eligibility. The move reflects the company’s financial performance and shareholder returns strategy.

May 2026MarketScreenerNews article

Jagran Prakashan Ltd’s stock price turns outright bearish as selling pressure intensifies. The stock closed at ₹68.00 on 10 February 2026, a 0.54% decline from ₹68.37, with intraday trading confined between ₹67.87 and ₹68.82. The company’s share price now sits near its 52-week low of ₹63.00, down from a high of ₹83.99, signaling weakening momentum.

Feb 2026MarketsMojoNews article